#	Pagina
attuale pagina	/open-h2020/projects/215849/index.html
-1	/open-fp7/projects/97416/index.html
-2	/open-fp7/projects/88142/index.html

Opendata, web and dolomites

NeuroMotive SIGNED

NeuroRobotics Platform Application to Traction Control for Automotive Industry

Total Cost €

EC-Contrib. €

Partnership

Views

NeuroMotive project word cloud

Explore the words cloud of the NeuroMotive project. It provides you a very rough idea of what is the project "NeuroMotive" about.

physical controllers service plan sophisticated road traction tuning business sp10 smts limited tools envisioned standard outreach laws amount mobility tested neurorobotics market function performance machine heavy validation siemens syl emulation loop emphasis setup connect car connected infrastructure capacity controller provision synthesize industry building innovation platform stakeholders nrp neural hbp automotive learning engagement

Project "NeuroMotive" data sheet

The following table provides information about the project.

Coordinator	TECHNISCHE UNIVERSITAET MUENCHEN Organization address address: Arcisstrasse 21 city: MUENCHEN postcode: 80333 website: www.tu-muenchen.de contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Germany [DE]
Total cost	100˙000 €
EC max contribution	100˙000 € (100%)
Programme	1. H2020-EU.1.2.1. (FET Open)
Code Call	H2020-FETOPEN-4-2016-2017
Funding Scheme	CSA
Starting year	2018
Duration (year-month-day)	from 2018-07-01 to 2019-12-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	TECHNISCHE UNIVERSITAET MUENCHEN TECHNISCHE UNIVERSITAET MUENCHEN Organization address address: Arcisstrasse 21 city: MUENCHEN postcode: 80333 website: www.tu-muenchen.de contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (MUENCHEN)	coordinator	85˙537.00
2	R.U.Robots Limited R.U.Robots Limited Organization address address: EDEN VALE 4 city: MANCHESTER postcode: M28 1WF website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	UK (MANCHESTER)	participant	14˙462.00

Map

Project objective

The work proposed aims at the development of a service in Traction Control for the automotive industry, building upon innovation from the NeuroRobotics Platform (NRP, HBP-SP10). The service will use the platform’s capacity to synthesize sophisticated neural control laws. Controllers developed will be tested on a unique infrastructure, the Siemens Mobility Test Setup (SMTS), which allows physical emulation of a wide range of road conditions for any car connected. This System-in-the-Loop (SyL) setup will support machine learning processes, allowing tuning of the traction controller to a high standard of performance, and provide early control-function validation and performance assessment. The work proposed involves: A limited amount of Technical Work, to connect NRP and SMTS, and develop the required service provision tools, Market Analysis and business plan development for the envisioned service, and a heavy emphasis on Outreach and Engagement of stakeholders and potential interested end-users.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NEUROMOTIVE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NEUROMOTIVE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.1.)

PANACHE (2020)

Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases.